Skip to main content
placeholder image

Correlation of PDL1 tumor expression and treatment outcomes in patients with renal cell carcinoma (RCC) receiving tyrosine kinase inhibitors: COMPARZ study analysis.

Journal Article


Abstract


UOW Authors


  •   De Souza, Paul (external author)

Publication Date


  • 2014

Citation


  • Choueiri, T. K., Figueroa, D. J., Liu, Y., Gagnon, R. C., Deen, K. C., Carpenter, C., . . . Motzer, R. J. (2014). Correlation of PDL1 tumor expression and treatment outcomes in patients with renal cell carcinoma (RCC) receiving tyrosine kinase inhibitors: COMPARZ study analysis.. Journal of Clinical Oncology, 32(4_suppl), 416. doi:10.1200/jco.2014.32.4_suppl.416

Web Of Science Accession Number


Start Page


  • 416

End Page


  • 416

Volume


  • 32

Issue


  • 4_suppl

Place Of Publication


Abstract


UOW Authors


  •   De Souza, Paul (external author)

Publication Date


  • 2014

Citation


  • Choueiri, T. K., Figueroa, D. J., Liu, Y., Gagnon, R. C., Deen, K. C., Carpenter, C., . . . Motzer, R. J. (2014). Correlation of PDL1 tumor expression and treatment outcomes in patients with renal cell carcinoma (RCC) receiving tyrosine kinase inhibitors: COMPARZ study analysis.. Journal of Clinical Oncology, 32(4_suppl), 416. doi:10.1200/jco.2014.32.4_suppl.416

Web Of Science Accession Number


Start Page


  • 416

End Page


  • 416

Volume


  • 32

Issue


  • 4_suppl

Place Of Publication